Old Web
A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis.
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
7
References
2
Citations
NaN
KQI